missing translation for 'onlineSavingsMsg'
Learn More
Learn More
RRx-001, MedChemExpress
Description
RRx-001, a hypoxia-selective epigenetic agent and studied as a radio- and chem-sensitizer, triggers apoptosis and overcomes drug resistance in myeloma. RRx-001 exhibits potent anti-tumor activity with minimal toxicity. RRx-001 is a dual small molecule checkpoint inhibitor by downregulating CD47 and SIRP-α. RRx-001 is a potent inhibitor of G6PD and shows potent antimalarial activity.
Specifications
Specifications
| Chemical Name or Material | RRx-001 |
| Physical Form | Solid |
| CAS | 925206-65-1 |
| Color | White |
| Quantity | 10 mg |
| Purity Grade Notes | Research |
| Molecular Formula | C5H6BrN3O5 |
| For Use With (Application) | Cancer-programmed cell death |
| Solubility Information | DMSO : ≥ 100 mg/mL (373.11 mM) |
| SMILES | BrCC(N1CC([N+]([O-])=O)([N+]([O-])=O)C1)=O |
| Show More |
Research purposes only
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?